Bayer Investments India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.01 Cr
as on 15-11-2024
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -14.51%
(FY 2023)
- Profit -15.10%
(FY 2023)
- Ebitda -14.58%
(FY 2023)
- Net Worth -10.63%
(FY 2023)
- Total Assets -18.02%
(FY 2023)
About Bayer Investments India
The Corporate was formerly known as Monsanto Investments India Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nabeel Tharakkandathil, Priya Murali, and Kunal Jha serve as directors at the Company.
- CIN/LLPIN
U65191MH2014PTC254886
- Company No.
254886
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2014
- Date of AGM
29 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bayer Investments India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Murali  | Director | 15-Apr-2020 | Current |
| Nabeel Tharakkandathil | Director | 19-Mar-2018 | Current |
| Kunal Jha | Director | 28-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Bayer Investments India.
Bayer Investments India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.51% decrease. The company also saw a substantial fall in profitability, with a 15.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bayer Investments India?
In 2023, Bayer Investments India had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mahyco Monsanto Biotech (India) Private LimitedActive 27 years 1 monthPriya Murali is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bayer Investments India?
Bayer Investments India has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bayer Investments India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Investments India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
